| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |